Security key
83422E204
Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB)
CUSIP: 83422E204
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 15,773,407
- Total 13F value
- $74,764,734
- Share change
- +514,654
- Put/Call ratio
- 6604%
- SEC-reported price per share
- $4.74
- Number of holders
- 35
- Value change
- +$2,205,404
- Number of buys
- 17
- Number of sells
- 12
- Shares outstanding
- 100,704,083
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
35
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
3.5%
RA CAPITAL MANAGEMENT, L.P.
3.4%
Bain Capital Life Sciences Invest...
3.1%
Camber Capital Management LP
1.4%
Laurion Capital Management LP
0.92%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
3.5%
|
$18,808,120
3,495,933 shares
|
— | 31 Dec 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.4%
|
$18,433,419
3,426,286 shares
|
— | 31 Dec 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
3.1%
|
$16,842,000
3,130,422 shares
|
— | 31 Dec 2022 |
| Camber Capital Management LP |
13F
Company
|
1.4%
|
$7,631,000
1,418,439 shares
|
— | 31 Dec 2022 |
| Laurion Capital Management LP |
13F
Company
|
0.92%
|
$4,993,549
928,169 shares
|
— | 31 Dec 2022 |
| Artal Group S.A. |
13F
Company
|
0.9%
|
$4,892,000
909,219 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
15,773,407
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
35
Q1 2023 holders
35
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|